Eton Pharmaceuticals, Inc.
- ETON
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Rare Disease Pharmaceuticals
- Specialty Drug Developer
$49.22
Today −2.17%Quote Oct 19, 2026, 08:00 PM UTC
−11.32%over the last month
Max drawdown −17.3%From 1-month high −17.3%3 months +13.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Eton Pharmaceuticals
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Employees
44
Founded
2017
Market value
$1.41B
Quote Oct 19
Floor
$48.83
0.8% below price
Resistance
$50.76
3.1% above price
Price vs analyst targets
7 analysts
Lowest target
$68.00Highest target
$78.00
$68.00Highest target
$78.00
- Price $49.22
- Average target $72.00
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 46% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ETONPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free